These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3089102)

  • 1. Quantitation of cutaneous Langerhans' cells of sarcoidosis patients.
    Berman B; Fox JL; Teirstein AS
    Ann N Y Acad Sci; 1986; 465():250-9. PubMed ID: 3089102
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of cutaneous Langerhans cells of sarcoidosis patients.
    Fox JL; Berman B; Teirstein AS; France DS; Reed ML
    J Invest Dermatol; 1983 Jun; 80(6):472-5. PubMed ID: 6574191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell membrane glycoproteins and Langerhans cells.
    Murphy GF
    Hum Pathol; 1985 Feb; 16(2):103-12. PubMed ID: 3882547
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
    Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
    Liu HH; Schroeter AL; Muller SA
    Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic studies on cutaneous lesions in sarcoidosis.
    Quismorio FP
    Clin Dermatol; 1986; 4(4):54-61. PubMed ID: 3542173
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidermal DR+T6- dendritic cells in inflammatory skin diseases.
    Baker BS; Lambert S; Powles AV; Valdimarsson H; Fry L
    Acta Derm Venereol; 1988; 68(3):209-17. PubMed ID: 2455413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathologic demonstration of T lymphocyte subpopulations and interleukin 2 in granuloma annulare.
    Modlin RL; Horwitz DA; Jordan RR; Gebhard JF; Taylor CR; Rea TH
    Pediatr Dermatol; 1984 Jul; 2(1):26-32. PubMed ID: 6438616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients.
    Sloane JP; Thomas JA; Imrie SF; Easton DF; Powles RL
    J Clin Pathol; 1984 Aug; 37(8):919-30. PubMed ID: 6381547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular distribution of HLA-DR and T6 antigens in the epidermis of various dermatoses.
    Willemze R; Dijkstra A; Nugteren WM
    Br J Dermatol; 1985 Dec; 113(6):802-4. PubMed ID: 3938294
    [No Abstract]   [Full Text] [Related]  

  • 12. Products of class II major histocompatibility complex gene subregions are differentially expressed on keratinocytes in cutaneous diseases.
    Barker JN; Ophir J; MacDonald DM
    J Am Acad Dermatol; 1988 Oct; 19(4):667-72. PubMed ID: 2460509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR-expressing Langerhans'-like cells in vaginal and cervical epithelium.
    Bjercke S; Scott H; Braathen LR; Thorsby E
    Acta Obstet Gynecol Scand; 1983; 62(6):585-9. PubMed ID: 6367339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
    Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
    Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of lymphoid and macrophage like cell subsets of sarcoid and Kveim granulomata: possible mechanism of negative PPD reaction in sarcoidosis.
    Mishra BB; Poulter LW; Janossy G; James DG
    Clin Exp Immunol; 1983 Dec; 54(3):705-15. PubMed ID: 6360446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
    Claudy AL; Rouchouse B
    Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of distinct subpopulations of Langerhans cells by flow cytometry and sorting.
    Vaigot P; Czernielewski J; Prunieras M
    Cytometry; 1985 Sep; 6(5):422-7. PubMed ID: 2931262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances of ultrastructural immunocytochemistry of epidermal Langerhans cells.
    Schmitt D; Dezutter-Dambuyant C; Faure M; Thivolet J
    Br J Dermatol; 1985 Jul; 113 Suppl 28():2-9. PubMed ID: 3925979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Langerhans' cells in oral lichen planus using monoclonal antibodies.
    Sloberg K; Jonsson R; Jontell M
    J Oral Pathol; 1984 Oct; 13(5):516-24. PubMed ID: 6434718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical markers in the normal human epibulbar conjunctiva from fetus to adult.
    Chan CC; Nussenblatt RB; Ni M; Li S; Mao W
    Arch Ophthalmol; 1988 Feb; 106(2):215-7. PubMed ID: 3257690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.